• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    H

    Heart Failure Society of America

    EST. 1994
    10论文总数
    2,595引用总数

    The Heart Failure Society of America is an American organization of heart failure experts who have an interest in heart function and heart failure. Founded in 1995, it provides a forum for experts and patients with the aim of reducing the burden of heart failure.It has produced advice on categorizing heart failure and it produces guidelines including the 2010 comprehensive heart failure practice guidelines when Douglas L. Mann was served as the president and the 2013 Guideline for the Management of Heart Failure. In 2018, a forum was created with people of various stages of advanced heart failure and specialists in cardiology.Past presidents have included Mandeep R. Mehra, who took up the position in 2016.

    论文量&引用量时间轴

    机构学者

    论文(10)

    年份
    起
    –
    止
    排序
    12025 ACC/AHA/ASE/ASNC/SCCT/SCMR Advanced Training Statement on Advanced Cardiovascular Imaging: A Report of the ACC Competency Management Committee.
    Lauren A Baldassarre,Lisa A Mendes,Ron Blankstein,Rebecca T Hahn,Amit R Patel, Raymond Russell,Suhny Abbara, Shawn M Ahmad, Mary Beth Brady,Renee P Bullock-Palmer,João L Cavalcante,Panithaya Chareonthaitawee,
    2026Circulation Cardiovascular imaging(2026)引用:4
    引用
    AI阅读
    加入学术空间
    2Advancing the Future of Heart Failure Care Through the HFSA Devices Initiative.
    Kenneth B Margulies
    2026Journal of cardiac failure(2026)
    引用
    AI阅读
    加入学术空间
    3Advancing Genetics and Heart Failure: HFSA Steps Forward to Lead.
    Kenneth B Margulies
    2026Journal of cardiac failure(2026)
    引用
    AI阅读
    加入学术空间
    42024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults with Heart Failure: A Report of the American Heart Association/American College of Cardiology Joint Committee on Performance Measures
    Writing Committee Members,Michelle M Kittleson,Khadijah Breathett,Boback Ziaeian,David Aguilar, Vanessa Blumer,Biykem Bozkurt,Rebecca L Diekemper, Michael P Dorsch,Paul A Heidenreich,Corrine Y Jurgens,Prateeti Khazanie,

    This document describes performance measures for heart failure that are appropriate for public reporting or pay-for-performance programs and is meant to serve as a focused update of the “2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.” The new performance measures are taken from the “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines” and are selected from the strongest recommendations (Class 1 or Class 3). In contrast, quality measures may not have as much evidence base and generally comprise metrics that might be useful for clinicians and health care organizations for quality improvement but are not yet appropriate for public reporting or pay-for-performance programs. New performance measures include optimal blood pressure control in patients with heart failure with preserved ejection fraction, the use of sodium-glucose cotransporter-2 inhibitors for patients with heart failure with reduced ejection fraction, and the use of guideline-directed medical therapy in hospitalized patients. New quality measures include the use of sodium-glucose cotransporter-2 inhibitors in patients with heart failure with mildly reduced and preserved ejection fraction, the optimization of guideline-directed medical therapy prior to intervention for chronic secondary severe mitral regurgitation, continuation of guideline-directed medical therapy for patients with heart failure with improved ejection fraction, identifying both known risks for cardiovascular disease and social determinants of health, patient-centered counseling regarding contraception and pregnancy risks for individuals with cardiomyopathy, and the need for a monoclonal protein screen to exclude light chain amyloidosis when interpreting a bone scintigraphy scan assessing for transthyretin cardiac amyloidosis.

    2024Journal of the American College of Cardiology(2024)引用:20
    引用
    AI阅读
    加入学术空间
    5HFSA: Serving Those Who Serve Heart Failure Patients
    John R. Teerlink

    “Serving those who serve” is a common phrase in my workplace and a principle to which I have dedicated my professional life. During the HFSA Annual Scientific Meeting in the Washington, DC area, I asked the Veterans in the audience to stand and be recognized for their service to our country. While conscious of differences in the types of service, I also acknowledged everyone in the audience, and you reading now, who have dedicated your career to serving heart failure patients and reaffirmed that the HFSA serves you.

    2022JOURNAL OF CARDIAC FAILURE(2022)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 10 篇论文

    合作机构(9)

    Association of Black Cardiologists合作论文 1
    American College of Emergency Physicians合作论文 1
    Heart Rhythm Society合作论文 1
    美国心脏协会合作论文 1
    Society of Cardiovascular Anesthesiologists合作论文 1
    American Society of Echocardiography合作论文 1
    Society for Cardiovascular Angiography and Interventions合作论文 1
    American Association for Thoracic Surgery合作论文 1
    Society of Critical Care Medicine合作论文 1

    机构统计